FR1513M - New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability. - Google Patents

New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability.

Info

Publication number
FR1513M
FR1513M FR873938A FR873938A FR1513M FR 1513 M FR1513 M FR 1513M FR 873938 A FR873938 A FR 873938A FR 873938 A FR873938 A FR 873938A FR 1513 M FR1513 M FR 1513M
Authority
FR
France
Prior art keywords
hyperemotivitis
hyperexcitability
manifestations
anxiety
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR873938A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR873938A priority Critical patent/FR1513M/en
Application granted granted Critical
Publication of FR1513M publication Critical patent/FR1513M/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D459/00Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR873938A 1961-06-23 1961-09-22 New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability. Active FR1513M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR873938A FR1513M (en) 1961-06-23 1961-09-22 New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR865894A FR1369323A (en) 1961-06-23 1961-06-23 New derivative of yohimbane and method of preparation
FR873938A FR1513M (en) 1961-06-23 1961-09-22 New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability.

Publications (1)

Publication Number Publication Date
FR1513M true FR1513M (en) 1962-10-01

Family

ID=8757905

Family Applications (2)

Application Number Title Priority Date Filing Date
FR865894A Expired FR1369323A (en) 1961-06-23 1961-06-23 New derivative of yohimbane and method of preparation
FR873938A Active FR1513M (en) 1961-06-23 1961-09-22 New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR865894A Expired FR1369323A (en) 1961-06-23 1961-06-23 New derivative of yohimbane and method of preparation

Country Status (1)

Country Link
FR (2) FR1369323A (en)

Also Published As

Publication number Publication date
FR1369323A (en) 1964-08-14

Similar Documents

Publication Publication Date Title
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1994M (en) New drug in particular for the treatment of manifestations due to hyperlipemia or hypercholesterolemia.
FR1215M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenia.
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR1513M (en) New drug in particular for the treatment of manifestations of hyperemotivitis, anxiety and disorders due to hyperexcitability.
FR1372M (en) New drug, in particular for the treatment of manifestations of hyperemotion, anxiety and disorders due to hyperexcitability.
FR1594M (en) New drug in particular for the treatment of hypercholesterolemia and disorders due to acute or chronic hyperlipemia.
FR1487M (en) New drug in particular for the treatment of disorders due to hyperlipemia.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2789M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR1203M (en) New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.
FR3031M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR3009M (en) New drug in particular for the treatment of protein anabolism and disorders due to hyperfolliculinia.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1485M (en) New drug in particular for the treatment of hyper cholesterolemia and the resulting disorders.
FR2974M (en) New drug in particular for the treatment of spasms of coronary origin and circulatory disorders.
FR1690M (en) New drug in particular for the treatment of respiratory disorders, bronchitis, pneumonia and heart collapse and failure.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.